CDSCO warns of 48 commonly used drugs failing quality tests.

The Central Drugs Standard Control Organization (CDSCO) has issued an alert about the List of Drugs, Medical Devices and Cosmetics declared as Not of Standard Quality/Spurious/Adulterated/Misbranded for the Month of March – 2023.

In this list released by CDSCO, Shockingly there were 48 drugs which are reported to have failed the quality test.

48 drugs include Popular Cardiac Drugs Telmisartan 40 mg and Amlodipine 5 mg Tablets IP (Telma-AM Tablets) from Glenmark, Meswak from Dabur India.